Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pancreatic Neoplasms × folfirinox × Clear all

Phase

Status

Completed 12 Unknown 8 Recruiting 6 Terminated 5 Active not recruiting 5 Withdrawn 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Colorectal Neoplasms 1

Interventions

Gemcitabine 17 irinotecan sucrosofate 7 Oxaliplatin 6 Leucovorin 6 Fluorouracil 6 130-nm albumin-bound paclitaxel 6 Taxes 4 Drug Therapy 4 toripalimab 3 S 1 (combination) 3 Radiosurgery 3 Injections 3 Albumin-Bound Paclitaxel 3 surufatinib 2 Paclitaxel 2 Irinotecan 2 Capecitabine 2 Blood Specimen Collection 2 Biopsy 2 zimberelimab 1 sintilimab 1 potassium oxonate 1 pembrolizumab 1 nimotuzumab 1 netrin-1 inhibitor NP137 1 gimeracil 1 folfirinox 1 disitamab vedotin 1 defactinib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07208539 2025-10-06

ZSPAC-14

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡